APR - 1 2004
Attachment 5
Koyooy!
$10(K) Summary of Safety and Effectiveness _
This 510(K) Summary of Safety and Effectiveness for the LuxV™ handpiece is
submitted in accordance with the requirements of Safe Medical Device Act (SMDA) of
1990 and follows the Office of Device Evaluation (ODE) guidance concerning the
organization and content of a 510(K) summary.
Applicant: Palomar Medical Technologies, Inc.
Address: 82 Cambridge St.
Burlington, MA 01803
781-993-2300
Contact Person: Marcy Moore
Telephone: 919-363-2432
Preparation Date: January 12, 2004
Device Trade Name: Palomar LuxV™ Handpiece
Common Name: Luxv™
Classification Name: Laser surgical instrument for use in General and
Plastic Surgery and in Dermatology
(see: 21 CFR 878-4810).
Product Code: GEX
Panel: 79
Legally-Marketed Predicate Device: ClearTouch by Radiancy, Candela Smoothbeam;
Laserscope Aura; ICN Photonics NLite
System Description:
The EsteLux Pulsed Light System with the Luxv™
handpiece accessory is a light-based medical device
designed for treatment of inflammatory acne.
Intended Use of the Device: /
The EsteLux™ System with the LuxV™ handpiece
is intended for the treatment of inflammatory acne
(acne vulgaris).
23

Performance Data: .
The differences in the specifications of the EsteLux
LuxV™ and the ClearTouch do not result in
different performance or raise new questions of
safety or efficacy. In addition, clinical data was
provided to support the safety and efficacy of the
LuxV handpiece.

Conclusion:
Based on the foregoing, the LuxV™ handpiece is
substantially equivalent to the legally marketed
claimed predicate devices.

24

er,
f a DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a
Food and Drug Administration
9200 Corporate Boulevard
APR = 1 2004 Rockville MD 20850
Ms. Marcy Moore
Manager of Clinical Studies
Palomar Medical Technologies, Inc.
131 Kelekent Lane
Cary, North Carolina 27511
Re: K040081
Trade/Device Name: LuxV™
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: January 13, 2004
Received: January 15, 2004
Dear Ms. Moore:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
/ general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Marcy Moore
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (2! CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain. html

Sincerely yours,

celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

INDICATIONS FOR USE STATEMENT
510(K) Number: 04008
Device Name: Luxv™
Indications for Use:
The LuxV™ handpiece is intended for the treatment of inflammatory acne
(acne vulgaris).
(Please do not write below this line - Continue on another page if needed) .
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use_\/ OR Over-the-Counter Use
(per 21 CFR 801.109)
Yrumane 0 Frevest
(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
| 510(k) Number_A24008/
8

